12/26 – 12/29 Biotech Moonshots Update
Profiting From $20-for-$1 Biotechs
The biotech bear market from February 2021 through October 2023 created some dramatically underpriced stocks. There is free money lying on the sidewalk, just waiting for you to pick it up.
Dear Biotechies:
I know I said there would be no update in this holiday week, but I wanted to share our performance for 2023. The portfolio added 1.6% from last week as the new biotech bull market gathers steam. There is much more to come in 2024!
* * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * *
The complete first chapter of my new book that I'm writing online, Every Investor's Guide to AI & Metaverse Stocks, is posted on Substack. It's free to read!
Introduction -
Chapter 1: Part A -
Chapter 1: Part B -
Chapter 1: Part C -
Enjoy and subscribe (free or paid) for future chapters!
Paid subscriber or not, if you would click the ♥ symbol below it would really help me get the word out.
Your Editor,
Michael Murphy CFA is a Harvard-trained economist with over 35 years of stock market experience as a security analyst on both the buy- and sell-side, as a Registered Investment Adviser, mutual fund manager, and Director of Research.